AURO LABORATORIES LTD.

Company Profile

AURO LABORATORIES LTD. had its IPO on under the ticker symbol AUROLAB.

The company operates in the sector and industry. AURO LABORATORIES LTD. has a staff strength of 0 employees.

Stock update

Shares of AURO LABORATORIES LTD. opened at ₹119.05 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹113.1 - ₹119.05, and closed at ₹114.6.

This is a -3.74% slip from the previous day's closing price.

A total volume of 9,777 shares were traded at the close of the day’s session.

In the last one week, shares of AURO LABORATORIES LTD. have slipped by -11.16%.

AURO LABORATORIES LTD.'s Key Ratios

AURO LABORATORIES LTD. has a market cap of ₹511.19 million, indicating a price to book ratio of 1.4661 and a price to sales ratio of 0.8787.

In the last 12-months AURO LABORATORIES LTD.’s revenue was ₹0 with a gross profit of ₹186.97 million and an EBITDA of ₹0. The EBITDA ratio measures AURO LABORATORIES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, AURO LABORATORIES LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, AURO LABORATORIES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

AURO LABORATORIES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

11.7828

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AURO LABORATORIES LTD.’s profitability.

AURO LABORATORIES LTD. stock is trading at a EV to sales ratio of 0.7893 and a EV to EBITDA ratio of 10.7664. Its price to sales ratio in the trailing 12-months stood at 0.8787.

AURO LABORATORIES LTD. stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹559.94 million

Total Liabilities

₹181.31 million

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

AURO LABORATORIES LTD. ended 2025 with ₹559.94 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹559.94 million while shareholder equity stood at ₹342.01 million.

AURO LABORATORIES LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹181.31 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹17.87 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹17.58 million.

AURO LABORATORIES LTD.’s total current assets stands at ₹356.62 million while long-term investments were ₹0 and short-term investments were ₹97.14 million. Its net receivables were ₹124.05 million compared to accounts payable of ₹114.80 million and inventory worth ₹117.56 million.

In 2025, AURO LABORATORIES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, AURO LABORATORIES LTD. paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹114.6

52-Week High

₹99

52-Week Low

₹52.5

Analyst Target Price

₹

AURO LABORATORIES LTD. stock is currently trading at ₹114.6 per share. It touched a 52-week high of ₹99 and a 52-week low of ₹99. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹91.94 and 200-day moving average was ₹77.3 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.